Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)

NCT04371666 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

98

Enrollment

INDUSTRY

Sponsor class

Stopped Study did not meet its primary endpoint.

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: Pamrevlumab
DRUG: Placebo
DRUG: Corticosteroids

Sponsor

Kyntra Bio